Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Diagnostic markers of axonal degeneration and demyelination in sensory nerve conduction.
Recent advances in the biomedical applications of fumaric acid and its ester derivatives: The multifaceted alternative therapeutics.
Extensive brain demyelinating lesions under natalizumab: The role of anti-natalizumab antibodies.
[Immunotherapies for multiple sclerosis : Review and update.]
Decoding the substrate supply to human neuronal nitric oxide synthase.
Childhood body mass index and multiple sclerosis risk: a long-term cohort study.
Therapeutic Plasma Exchange in Glucocorticosteroid-Unresponsive Patients With Clinically Isolated Syndrome.
Interventions for children coping with parental multiple sclerosis: A systematic review.
Antibodies identified by cell-based assays in myasthenia gravis and associated diseases.
PET Imaging of Disease Progression and Treatment Effects in the Experimental Autoimmune Encephalomyelitis Rat Model.
Predictors of quality of life in patients with relapsing-remitting multiple sclerosis: A 2-year longitudinal study.
Differential neuroprotective effects of 5'-deoxy-5'-methylthioadenosine.
A case series of autoimmune diseases accompanied by incidentally diagnosed monoclonal gammopathy: Is there a link between the two diseases?
[Illness, health and sunlight].
Thymic Atrophy and Apoptosis of CD4+CD8+ Thymocytes in the Cuprizone Model of Multiple Sclerosis.
MS Trust critical of guidance on multiple sclerosis.
Epstein-Barr virus is a necessary causative agent in the pathogenesis of multiple sclerosis: No.
Atypical presentation of multiple sclerosis.
Autoimmune Demyelinating Polyneuropathy as a Manifestation of Chronic Graft-versus-Host Disease after Adult Cord Blood Transplantation in a Patient with Chronic Lymphocytic Leukemia.
Purinergic mechanisms in neuroinflammation: An update from molecules to behavior.
Reconstruction of single cortical projection neurons reveals primary spine loss in multiple sclerosis.
[Immunoregulative effect of Fasudil on encephalomyelitic T cells in experimental autoimmune encephalomyelitis mice].
Targeting FcRn for therapy: From live cell imaging to in vivo studies in mice.
Intrathecal synthesis in particular types of multiple sclerosis.
Motor network efficiency and disability in multiple sclerosis.
Pages
« first
‹ previous
…
558
559
560
561
562
563
564
565
566
…
next ›
last »